/Investor DB

Mission Biocapital — 2022 Investments

3 investments dated 2022 · listed companies and verified rows first · show all

Telo Therapeutics, Inc.telotherapeutics.cominJun 2022SEC filingmedium confidence

Telo Therapeutics is a biotechnology company developing orally bioavailable next-generation small-molecule inhibitors of nuclear transport as cancer treatments.

BiotechHealthtechMedical DevicesSan Francisco, US

Rob Bell(Founder)inRobert Bell Ph.D.(CEO & Co-Founder)Joseph Costello(Director)Michael D. Taylor(Director)in

BoardRobert G. Blazej(Director)in

Board seatRobert BlazejMichael Taylor· per SEC Form D · $10.2M raise · filed Jun 2022

Arkuda Therapeuticsarkudatx.cominFeb 2022 · $64M

Arkuda is an independent information platform that provides analysis and reviews of online gaming platforms operating in Azerbaijan, focusing on legal compliance, security protocols, and user protection for gaming platforms like Mostbet.

ConsumerGamingBaku, AZ

Co-investorsAtlas VenturePfizer Venture InvestmentsPfizer VenturesPivotal Life Sciences

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Ribonaut Therapeutics

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.